mrmarket.ai
Stock Overview

Dr. Reddy’s Laboratories Ltd ADR (RDY)

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic

Dr. Reddy’s Laboratories Ltd ADR is a Healthcare company with a market capitalization of $10.42B, a trailing P/E ratio of 29.8, and a dividend yield of 0.66%.

Market Cap
$10.42B
P/E (TTM)
29.8
Forward P/E
27.2
Price/Sales
0.0
Price/Book
2.6
EV/EBITDA
14.5
Dividend Yield
0.66%
Beta
0.24
EPS (TTM)
$0.42
Profit Margin
12.7%
ROE
8.8%
Short % of Float
0.6%
Days to Cover
7.2
52W High
$15.40
52W Low
$11.40

5-Year Price History

Latest Annual Financials · FY ending March 31, 2026 · in INR

Revenue
353.47B INR
Gross Profit
186.52B INR
Operating Income
48.87B INR
Net Income
45.09B INR
Free Cash Flow
32.10B INR
Total Debt
76.05B INR
Cash & Equivalents
15.06B INR
Shareholder Equity
369.60B INR

Recent Quarterly Earnings (EPS)

QuarterReportedActual EPSEstimateSurprise
Q4 2026May 11, 2026$0.00$0.16-100.0%
Q3 2026January 20, 2026$0.16$0.16+1.9%
Q2 2026October 24, 2025$0.20$18.31-98.9%
Q1 2026July 23, 2025$17.02$0.21+8004.8%
Q4 2025May 9, 2025$19.11$17.13+11.6%
Q3 2025January 29, 2025$16.94$16.15+4.9%

Short Interest

FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.

SettlementShares Short% of Shares OutDays to CoverChange
July 15, 202620,975,049—7.2-9.5%
June 30, 202623,186,031—6.6+1.4%
June 15, 202622,854,885—16.7+2.1%
May 29, 202622,387,669—13.1+10.9%
May 15, 202620,180,379—5.7+28.4%
April 30, 202615,719,527—5.6+18.7%
April 15, 202613,238,551—5.5-9.6%
March 31, 202614,646,750—6.3+6.7%

Other Drug Manufacturers - Specialty & Generic Stocks

TAK
Takeda Pharmaceutical Co Ltd ADR
$55.20B
HLN
Haleon plc
$43.55B
TEVA
Teva Pharma Industries Ltd ADR
$41.60B
ZTS
Zoetis Inc
$30.42B
UTHR
United Therapeutics Corporation
$21.87B
VTRS
Viatris Inc
$18.59B
NBIX
Neurocrine Biosciences Inc
$15.19B
ELAN
Elanco Animal Health
$11.15B
RDY vs TAKRDY vs HLNRDY vs TEVA

Frequently Asked Questions

What is Dr. Reddy’s Laboratories Ltd ADR's market cap?

As of August 13, 2026, Dr. Reddy’s Laboratories Ltd ADR (RDY) has a market capitalization of $10.42B.

What is Dr. Reddy’s Laboratories Ltd ADR's P/E ratio?

Dr. Reddy’s Laboratories Ltd ADR trades at a trailing price-to-earnings (P/E) ratio of 29.8. Its forward P/E is 27.2.

Does Dr. Reddy’s Laboratories Ltd ADR pay a dividend?

Yes — Dr. Reddy’s Laboratories Ltd ADR pays a dividend yielding 0.66%, an annual payout of $8.00 per share.

What sector is RDY in?

Dr. Reddy’s Laboratories Ltd ADR is in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.

What is Dr. Reddy’s Laboratories Ltd ADR's short interest?

As of the July 15, 2026 FINRA settlement, 20,975,049 RDY shares were sold short. Days to cover: 7.2. FINRA publishes short interest twice a month, about nine business days after each settlement date.

What was Dr. Reddy’s Laboratories Ltd ADR's revenue?

In its latest reported fiscal year (ending March 31, 2026), Dr. Reddy’s Laboratories Ltd ADR reported revenue of 353.47B INR and net income of 45.09B INR.

Ask your own questions about RDY

Try mrmarket.ai free

Data as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.